PBF-677

DRUG2 trials

Sponsors

Palobiofarma SL

Conditions

GlaucomaUlcerative Colitis

Phase 1

First-in-human Study To Assess the Safety and Tolerability of PBF-677 in Healthy Volunteers

CompletedNCT02639975

Palobiofarma SLGlaucoma

Start: 2015-12-31End: 2016-06-30Updated: 2018-12-17

Phase 2

Safety and Efficacy of PBF-677 in Ulcerative Colitis Patients

CompletedNCT03773952

Palobiofarma SLUlcerative Colitis

Start: 2018-07-01End: 2021-05-27Updated: 2022-01-13